--- title: "Xylo Tech (XYLO.US)" type: "quote" locale: "en" url: "https://longbridge.com/en/quote/XYLO.US.md" symbol: "XYLO.US" name: "Xylo Tech" industry: "Health Care Equipment" --- # Xylo Tech (XYLO.US) | Item | Detail | |------|--------| | Industry | Health Care Equipment | ## Company Profile Xylo Technologies Ltd, a technology-based company, provides medical-related devices and products in the United States, Europe, Great Britain, Israel, Canada, Asia, and internationally. It operates through Corporate, Online Advertising & Internet Traffic Routing, Online Event Management, and Real-est... ## Financial Score > *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.* > Updated: 2026-02-26T04:30:14.000Z **Overall: D (0.69)** **Industry**: Health Care Equipment | Metric | Value | |--------|-------| | Industry Ranking | 166 / 185 | | Industry Median | C | | Industry Average | C | - **Style**: Value - Stocks where the company's main business is in a mature stage. - **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns. ### Score Analysis **Style Score**: #### Growth Score: | Indicator | Value | Rating | |-----------|-------|--------| | Revenue YoY | -67.45% | | | Net Profit YoY | 62.39% | | #### Value Score: | Indicator | Value | Rating | |-----------|-------|--------| | P/B Ratio | 0.00 | | | Dividend Ratio | 0.00% | | **Size Score**: #### Market Cap Score: | Indicator | Value | Rating | |-----------|-------|--------| | Market Cap | 0.00 | | #### Revenue Score: | Indicator | Value | Rating | |-----------|-------|--------| | Revenue | 29.86M | | **Multi Score**: D #### Profit Score: D | Indicator | Value | Rating | |-----------|-------|--------| | ROE | -29.00% | E | | Profit Margin | -20.19% | D | | Gross Margin | 22.38% | D | #### Growth Score: E | Indicator | Value | Rating | |-----------|-------|--------| | Revenue YoY | -67.45% | E | | Net Profit YoY | 62.39% | B | | Total Assets YoY | -41.23% | E | | Net Assets YoY | -45.77% | E | #### Cash Score: E | Indicator | Value | Rating | |-----------|-------|--------| | Cash Flow Margin | -495.40% | E | | OCF YoY | -67.45% | E | #### Operating Score: B | Indicator | Value | Rating | |-----------|-------|--------| | Turnover | 0.59 | B | #### Debt Score: C | Indicator | Value | Rating | |-----------|-------|--------| | Gearing Ratio | 53.16% | C | ```chart-data:radar { "title": "Longbridge Financial Score - Xylo Tech", "chart_type": "radar", "dimensions": [ { "name": "Profit", "grade": "D", "indicators": [ { "name": "ROE", "value": "-29.00%", "rating": "E" }, { "name": "Profit Margin", "value": "-20.19%", "rating": "D" }, { "name": "Gross Margin", "value": "22.38%", "rating": "D" } ] }, { "name": "Growth", "grade": "E", "indicators": [ { "name": "Revenue YoY", "value": "-67.45%", "rating": "E" }, { "name": "Net Profit YoY", "value": "62.39%", "rating": "B" }, { "name": "Total Assets YoY", "value": "-41.23%", "rating": "E" }, { "name": "Net Assets YoY", "value": "-45.77%", "rating": "E" } ] }, { "name": "Cash", "grade": "E", "indicators": [ { "name": "Cash Flow Margin", "value": "-495.40%", "rating": "E" }, { "name": "OCF YoY", "value": "-67.45%", "rating": "E" } ] }, { "name": "Operating", "grade": "B", "indicators": [ { "name": "Turnover", "value": "0.59", "rating": "B" } ] }, { "name": "Security", "grade": "C", "indicators": [ { "name": "Gearing Ratio", "value": "53.16%", "rating": "C" } ] } ] } ``` ### Peer Comparison | Rank | Name | Profit | Growth | Operation | Security | Cash | Rating | |------|------|--------|--------|-----------|----------|------|--------| | 01 | Inspire Medical (US.INSP) | A | B | A | A | B | A | | 02 | Delcath (US.DCTH) | C | A | A | A | A | A | | 03 | Abbott Laboratories (US.ABT) | B | C | C | B | C | B | | 04 | Intuitive Surgical (US.ISRG) | A | B | C | A | B | B | | 05 | Stryker (US.SYK) | A | B | C | C | B | B | ## Valuation Analysis | Metric | Current | Industry Ranking | High | Median | Low | |--------|---------|-----------------|------|--------|-----| | PE (TTM) | -1.08 | 84/181 | - | - | - | | PB | 0.36 | 9/181 | 0.36 | 0.36 | 0.34 | | PS (TTM) | 0.22 | 10/181 | 0.22 | 0.22 | 0.21 | | Dividend Yield | 0.00% | - | - | - | - | ## Institutional View ### Target Price Forecast | Metric | Price | |--------|-------| | Current Price | 5.07 | | Highest Target | 9.00 | | Lowest Target | 9.00 | ## References - [Company Overview](https://longbridge.com/en/quote/XYLO.US/overview.md) - Shareholders, executives, business segments - [Financials](https://longbridge.com/en/quote/XYLO.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan - [Topics & Discussions](https://longbridge.com/en/quote/XYLO.US/topics.md) - Community topics and discussions --- > **Disclaimer**: This article is for reference only and does not constitute any investment advice.